IRIS

Pneumocystis jirovecii pneumonia in COVID-19: an overlooked clinical entity—Response to “Pneumocystis pneumonia risk among viral acute respiratory distress syndrome related or not to COVID 19” / Buonomo, A. R.; Viceconte, G.; Gentile, I.. - In: CRITICAL CARE. - ISSN 1364-8535. - 25:1(2021). [10.1186/s13054-021-03836-7]

Pneumocystis jirovecii pneumonia in COVID-19: an overlooked clinical entity—Response to “Pneumocystis pneumonia risk among viral acute respiratory distress syndrome related or not to COVID 19”

Buonomo A. R.;Viceconte G.;Gentile I.
2021
2021
CRITICAL CARE
Pneumocystis jirovecii pneumonia in COVID-19: an overlooked clinical entity—Response to “Pneumocystis pneumonia risk among viral acute respiratory distress syndrome related or not to COVID 19” / Buonomo, A. R.; Viceconte, G.; Gentile, I.. - In: CRITICAL CARE. - ISSN 1364-8535. - 25:1(2021). [10.1186/s13054-021-03836-7]
1.1 Articolo in rivista
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11588/991236
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 2
  • ???jsp.display-item.citation.isi??? 2
social impact